Risk of fluctuations in the value of assets, including land and securities
First written in FY2016. 2 of 27 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2019: 10 of 23 companies on the "Worse" side.
4 other companies' latest entry also says "Other".
- FY2026Increase in valuation differencesAnnual report
「This was mainly due to increases of ¥349 million in retained earnings and ¥67 million in the valuation difference on other marketable securities, among other factors.」
The valuation difference on other marketable securities increased by ¥67 million from the end of the previous fiscal year, and the valuation difference on investment securities is stated as a factor in the increase in net assets. - FY2026-H1Increase in investment securities valuation differenceAnnual report
「Investment securities 288,660 422,134 Valuation difference on other marketable securities 88,125 180,184」
The balance of investment securities increased from ¥288,660 thousand at the end of the previous consolidated fiscal year to ¥422,134 thousand, while the valuation difference on other marketable securities also increased from ¥88,125 thousand to ¥180,184 thousand. No recognition of impairment losses is stated. - FY2025-H1Decrease in investment securities balance and valuation differenceAnnual report
「Investment securities 276,603 254,547」
The balance of investment securities decreased by ¥22.056 million, from ¥276,603 thousand at the end of the previous consolidated fiscal year to ¥254,547 thousand. The valuation difference on other marketable securities also decreased from ¥81,709 thousand to ¥65,403 thousand, but no recognition of impairment losses is stated. - FY2024-Q3Increase in investment securities balance and valuation differenceAnnual report
「Investment securities 233,644 282,142 Valuation difference on other marketable securities 48,210 84,633」
The balance of investment securities increased from ¥233,644 thousand at the end of the previous consolidated fiscal year to ¥282,142 thousand, while the valuation difference on other marketable securities also increased from ¥48,210 thousand to ¥84,633 thousand. - FY2024-Q2Increase in investment securities balance and valuation differenceAnnual report
「Investment securities 233,644 242,218」
The balance of investment securities increased from ¥233,644 thousand at the end of the previous consolidated fiscal year to ¥242,218 thousand. The valuation difference on other marketable securities also increased from ¥48,210 thousand to ¥53,856 thousand. - FY2024-Q1Increase in Investment Securities BalanceAnnual report
「Investment securities 233,644 244,635」
The balance of investment securities increased by ¥10.991 million, from ¥233,644 thousand at the end of the previous consolidated fiscal year to ¥244,635 thousand. - FY2023Increase in valuation difference; no impairment loss recognizedAnnual report
「Total net assets at the end of the current consolidated fiscal year amounted to ¥5,653 million, an increase of ¥217 million from the end of the previous consolidated fiscal year. This was due to increases of ¥188 million in retained earnings and ¥29 million in the valuation difference on other marketable securities.」
The valuation difference on other marketable securities increased by ¥29 million from the end of the previous fiscal year. No impairment loss on investment securities was recognized, and the fluctuation in asset values is stated as an increase in the valuation difference. - FY2023-Q3Increase in valuation differencesAnnual report
「This was due to increases of ¥21 million in retained earnings and ¥6 million in the valuation difference on other marketable securities.」
The valuation difference on other marketable securities increased by ¥6 million from the end of the previous consolidated fiscal year. Fluctuations in asset values can be confirmed, but this filing does not state that an impairment loss was recognized. - FY2023-Q2Decrease in Valuation DifferenceAnnual report
「Valuation difference on other marketable securities 18,537 17,256」
The valuation difference on other marketable securities decreased by ¥1.281 million, from ¥18,537 thousand at the end of the previous consolidated fiscal year to ¥17,256 thousand. - FY2023-Q1Decrease in Valuation DifferenceAnnual report
「Valuation difference on other marketable securities 18,537 14,592」
The valuation difference on other marketable securities decreased by ¥3.944 million, from ¥18,537 thousand at the end of the previous consolidated fiscal year to ¥14,592 thousand. - FY2022-Q3Continued decrease in valuation differenceAnnual report
「This was due to retained earnings increasing by ¥35 million, despite a ¥13 million decrease in the valuation difference on other marketable securities.」
The valuation difference on other marketable securities decreased by ¥13 million. Fluctuations in asset values can be confirmed, but this filing does not state that an impairment loss on investment securities was recognized. - FY2022-Q2Decrease in Valuation DifferenceAnnual report
「Valuation difference on other marketable securities 48,257 39,073」
The valuation difference on other marketable securities decreased by ¥9.183 million, from ¥48,257 thousand at the end of the previous consolidated fiscal year to ¥39,073 thousand. - FY2022-Q1MitigatedAnnual report
「This was due to retained earnings decreasing by △¥50 million and the valuation difference on other marketable securities increasing by ¥11 million.」
The valuation difference on other marketable securities increased by ¥11 million from the end of the previous fiscal year, with improvement stated in terms of the valuation difference resulting from fluctuations in asset values. - FY2021MaterialisedAnnual report
「During the current consolidated fiscal year, an impairment loss of ¥43.839 million was recognized on securities, consisting of ¥43.839 million on shares classified as other marketable securities.」
An impairment loss on investment securities of ¥43.839 million was recognized for the full fiscal year, indicating that the asset value fluctuation risk materialized as an actual loss. - FY2021-Q3MitigatedAnnual report
「Valuation difference on other marketable securities △11,403 46,771」
The valuation difference on other marketable securities increased from negative ¥11.403 million at the end of the previous consolidated fiscal year to ¥46.771 million, turning positive from negative. Separate from the impairment loss on investment securities recognized through the previous quarter, improvement can be confirmed in terms of the valuation difference. - FY2021-Q2MaterialisedAnnual report
「Impairment loss on investment securities － 43,839」
An impairment loss on investment securities of ¥43.839 million was recognized as an extraordinary loss during the six-month period of the current second quarter consolidated cumulative period, indicating that the asset value fluctuation risk materialized as an impairment loss. - FY2021-Q1Continued decrease in valuation differenceAnnual report
「Valuation difference on other marketable securities △11,403 △13,868」
The valuation difference on other marketable securities decreased by ¥2,465 thousand, from △¥11,403 thousand at the end of the previous consolidated fiscal year to △¥13,868 thousand. - FY2020WorsenedAnnual report
「This was due to retained earnings decreasing by △¥19 million and the valuation difference on other marketable securities also decreasing by △¥32 million.」
The valuation difference on other marketable securities changed from ¥21 million to △¥11 million, becoming negative. Fluctuations in the value of held assets are reflected as a factor in the decrease in net assets. - FY2020-Q3Decrease in Valuation DifferenceAnnual report
「This was due to retained earnings increasing by ¥32 million, despite a ¥34 million decrease in the valuation difference on other marketable securities.」
The valuation difference on other marketable securities decreased by ¥34 million. Fluctuations in asset values can be confirmed, but no recognition of impairment losses is stated. - FY2020-Q2Increase in valuation differencesAnnual report
「This was mainly due to increases of ¥8 million in the valuation difference on other marketable securities and ¥11 million in retained earnings.」
The valuation difference on other marketable securities increased by ¥8.422 million, from ¥21,014 thousand at the end of the previous consolidated fiscal year to ¥29,437 thousand. Fluctuations in asset values can be confirmed, but the recognition of valuation gains is not explicitly stated. - FY2020-Q1Slight decrease in valuation differencesAnnual report
「Valuation difference on other marketable securities 21,014 20,509」
The valuation difference on other marketable securities decreased by ¥505 thousand, from ¥21,014 thousand at the end of the previous consolidated fiscal year to ¥20,509 thousand. No recognition of impairment losses is stated. - FY2019Continued decrease in valuation differenceAnnual report
「This was due to retained earnings increasing by ¥128 million, despite a decrease of △¥49 million in the valuation difference on other marketable securities.」
The valuation difference on other marketable securities decreased by ¥49 million. Fluctuations in asset values can be confirmed, but no recognition of impairment losses is stated. - FY2019-Q3Continued decrease in valuation differenceAnnual report
「This was due to retained earnings increasing by ¥124 million, despite a ¥40 million decrease in the valuation difference on other marketable securities.」
A ¥40 million decrease in the valuation difference on other marketable securities is stated. However, no recognition of impairment losses is stated. - FY2019-Q2Decrease in valuation difference on other marketable securitiesAnnual report
「Valuation difference on other marketable securities 70,977 24,515」
The valuation difference on other marketable securities decreased by ¥46.462 million, from ¥70,977 thousand at the end of the previous fiscal year to ¥24,515 thousand. Fluctuations in asset values can be confirmed, but no recognition of impairment losses is stated. - FY2018RestatedAnnual report
「Due to economic conditions and other factors, declines in the value of assets held by the Group, including land and marketable securities, may result in impairment losses and other effects, and fluctuations in asset values may affect the Group's operating results and financial condition.」
The risk of impairment losses resulting from declines in the value of land, marketable securities and other assets continues to be disclosed. - FY2017RestatedAnnual report
「Due to economic conditions and other factors, declines in the value of assets held by the Group, including land and marketable securities, may result in impairment losses and other effects, and fluctuations in asset values may affect the Group's operating results and financial condition.」
The risk of impairment losses resulting from declines in the value of land, marketable securities and other assets continues to be disclosed. - FY2016First statedAnnual report
「The value of assets held by the Group, including land and marketable securities, may decline, potentially resulting in impairment losses.」
The possibility of declines in the market value of held assets and the recognition of impairment losses is disclosed.